Louise Gagnon[email protected]Diagnostic TechnologiesCOVID-19 testing offers chance for diabetes screening, tooStudy investigators hypothesized that they could leverage the existing COVID-19 testing infrastructure to also test for prediabetes and diabetes in a Latinx community that might otherwise face substantial barriers to care engagement.May 26, 2022Stomach CancerDr. Elizabeth Stern: A pioneer in cytopathology screeningEarly yearsMarch 28, 2022Sickle Cell AnemiaHalf of world lacks access to diagnostic testingThe objective of the report was to quantify the state of diagnostics across the globe, according to Susan Horton, one of the members of the Lancet Commission on diagnostics who contributed to the preparation of the report and a professor of global health economics at the University of Waterloo in Canada.October 11, 2021Page 1 of 1Top StoriesFDA ClearancePillar Biosciences gets FDA approval for NGS solid tumor profiling testPillar Biosciences has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its OncoReveal CDx pan-cancer next-generation sequencing (NGS) test for general solid tumor profiling.ValidationImmunovia announces positive results for next-gen pancreatic cancer testCollaborationVertex to pay $25M upfront to scale cell manufacturing technologyMergers & AcquisitionsLabcorp buys Invitae portfolio for $239MSponsor ContentVisit our Molecular Diagnostics Community